Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Climatotherapy At The Dead Sea For Atopic Dermatitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01307150
First received: July 6, 2009
Last updated: March 1, 2011
Last verified: July 2009
  Purpose

The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.


Condition
Atopic Dermatitis

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: Evaluation of the Efficacy of Dead Sea Climatotherapy on Atopic Dermatitis Patients.

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 50
Study Start Date: June 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
Before and after treatment
SCORAD of each patient before and after treatment.

Detailed Description:

28 days treatment period, sun exposure and possibly Dead Sea baths after an exact given plan, discontinuation of all local Cortisone preparations, unlimited use of maintenance drags, doctor visit twice a week, continuous checks by the nurse.

Determination of the SCORAD index by the same doctor on arrival and departure. Before and after the treatment, the patient will answer written questionnaires regarding quality of life.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Atopic Dermatitis patient.

Criteria

Inclusion Criteria:

  • Minimum age of 18 years old

Exclusion Criteria:

  • Skin type - I
  • Psoriasis patient in addition to Atopic Dermatitis
  • Pregnancy
  • Past malignancy
  • Less then 2 weeks of treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01307150

Contacts
Contact: Arik Tzukert, DMD +972-(0)2-6776095 arik@hadassah.org.il
Contact: Hadas Lemberg, PhD +972-(0)2-6777572 1hadas@hadassah.org.il

Locations
Israel
DMZ Clinic Not yet recruiting
Jerusalem, Israel
Contact: Marco Harari, Dr.    +972-(0)8-6689200    Doctor@LotHotel.co.il   
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Study Chair: Arie Ingber, MD. Hadassa Medical Organization IRB
  More Information

Publications:
Responsible Party: Hasassah Medical Organization IRB, Israel Ministry of Health
ClinicalTrials.gov Identifier: NCT01307150     History of Changes
Other Study ID Numbers: SK09409-HMO-CTIL
Study First Received: July 6, 2009
Last Updated: March 1, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
Atopic Dermatitis
Dead Sea
Climatotherapy
SCORAD

Additional relevant MeSH terms:
Dermatitis
Dermatitis, Atopic
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Genetic

ClinicalTrials.gov processed this record on November 25, 2014